Nov. 6 News: Daily COVID-19 cases, FDA panel reviews Alzheimer's drug, Unemployment drops, Vaccine trial data

NPR – New daily U.S. coronavirus cases jump nearly 20%, hitting almost 122,000

The U.S. recorded nearly 122,000 new daily coronavirus cases in data released Friday, a sharp uptick over the previous day that saw the country's first six-figure increase since the start of the pandemic.

Associated Press – FDA panel reviews 1st new Alzheimer’s drug in 2 decades

One of the biggest drug decisions in decades is looming as U.S. regulators consider whether to approve the first medicine that’s claimed to slow mental decline from Alzheimer’s disease, the most common form of dementia.

Associated Press – AstraZeneca to deliver vaccine trial data by year’s end

AstraZeneca hopes to show its COVID-19 vaccine is effective by the end of this year and is ramping up manufacturing so it can supply hundreds of millions of doses starting in January, Chief Executive Pascal Soriot said Thursday.

NPR – Unemployment drops, but pandemic surge clouds hopes for recovery

U.S. employers added 638,000 jobs last month, as the economy continued its slow recovery from the coronavirus recession. Job growth slowed for the fourth month in a row.

NPR – Many places hard hit by COVID-19 leaned more toward Trump in 2020 than 2016

Support for President Trump increased in 2020 in many of the U.S. counties that lost lives at the highest rate to COVID-19, according to an NPR analysis.